Monday 15 October 2018
Contact US    |    Archive
Reuters
25 days ago

Takeda lung cancer drug gets European panel nod

Takeda Pharmaceutical Co s lung cancer drug received the recommendation of a European Union panel on Friday, more than a year after it won regulatory approval to be sold in the United States.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Takeda

 | 

lung

 | 

cancer

 | 

drug

 | 

gets

 | 

European

 | 

panel

 | 

nod

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)